查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1373930

细胞株开发市场，按产品、按细胞系类型、按应用、按国家和地区 - 2023-2030 年行业分析、市场规模、市场份额和预测

Cell Line Development Market, By Product, By Type of Cell Lines, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 333 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2022年细胞株开发市场规模为48.1亿美元，2023年至2030年复合CAGR为9.81%。

细胞株开发市场-市场动态

生物製药和个人化医疗需求不断增长推动市场需求

不断扩大的生物製药产业对适合生产复杂生物疗法药物（包括单株抗体和基因疗法）的可靠且高效的细胞系产生了不断增长的需求。此外，对个人化医疗的强调强调了针对患者特异性细胞系来製作定製药物并促进临床前测试的必要性。这项要求推动了持续的研究和开发工作，旨在建立更具弹性、高产量和多功能的细胞系。这反过来又加速了针对多种疾病和医疗状况的新型标靶疗法的进步和可及性。

细胞株开发市场 - 关键见解

根据我们的研究分析师的调查结果，全球细胞株开发市场预计在 2023 年至 2030 年的预测期内年增长率约为 4.2%。

细胞株开发领域有望大幅扩张，这主要归因于兽医肿瘤学领域对精准医学的日益关注。

在考虑按产品细分时，试剂和介质成为 2022 年的主导类别。

从细胞系类型来看，重组细胞系在2022年的产品类别中处于领先地位。

从地理上看，亚太地区在 2022 年的收入创造方面处于领先地位。

细胞株开发市场-細項分析：

全球细胞株开发市场围绕着几个关键维度构建，包括产品、细胞系类型、应用和地区。

在产品分类方面，市场分为四个主要部分：试剂和介质、设备、配件和消耗品以及服务。值得注意的是，在此分类中，试剂和介质优先。细胞系的开发很大程度上依赖各种专门的试剂和细胞培养基。为细胞生长、维护和生产力提供理想环境的必要性推动了对这些基本组件的需求。这些产品是建立和维持研究和生物製造应用的高品质细胞係不可或缺的工具。

细胞株开发市场-地理洞察

从地理角度来看，该市场涵盖广泛的地区，包括北美、拉丁美洲、欧洲、亚太地区、中东和非洲。在这些地区，各国在促进商业活动方面发挥着重要作用。亚太地区对细胞系开发服务和专业知识的需求一直在稳步增长。这种趋势可以归因于多种因素。首先，该地区蓬勃发展的生物技术和製药产业加大了对可靠细胞系的需求，以促进药物研究和开发工作。

细胞株开发市场-竞争格局：

细胞系开发的竞争格局是成熟企业和新兴企业的混合体。 Lonza、Thermo Fisher Scientific 和 WuXi Biologics 等公司提供全面的服务和技术。他们透过展示技术创新、规模和专业知识来参与竞争。另一方面，像 Selexis 和 Solentim 这样的小公司专注于特定的利基市场，提供专业的解决方案和尖端平台。

目录

第一章：细胞株开发市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场摘录
    • 细胞株开发市场摘录（按产品）
    • 按细胞株开发市场摘录
    • 按应用分類的细胞株开发市场摘录
    • 按国家/地区分類的细胞株开发市场摘录
    • 按地区分類的细胞株开发市场摘录
  • 竞争洞察

第 3 章：细胞株开发主要市场趋势

  • 细胞株开发市场驱动因素
    • 市场驱动因素的影响分析
  • 细胞株开发市场限制
    • 市场限制影响分析
  • 细胞株开发市场机会
  • 细胞株开发市场未来趋势

第 4 章：细胞株开发产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：细胞株开发市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：细胞株开发市场格局

  • 2022 年细胞株开发市占率分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：细胞株开发市场 - 副产品

  • 概述
    • 按产品分類的细分市场占有率分析
    • 试剂和介质
    • 装置
    • 配件及消耗品
    • 服务

第 8 章：细胞株开发市场 - 依细胞系类型

  • 概述
    • 按细胞系类型分類的细分市场份额分析
    • 重组细胞系
    • 杂交瘤
    • 连续性细胞系
    • 原代细胞系

第 9 章：细胞株开发市场 -按应用

  • 概述
    • 按应用的细分市场占有率分析
    • 生物生产
    • 药物发现
    • 毒性测试
    • 组织工程
    • 其他的

第 10 章：细胞株开发市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美细胞株开发主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按产品）
    • 北美市场规模和预测（按细胞系类型）
    • 北美市场规模和预测（按应用）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲细胞株开发主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模与预测（按产品）
    • 欧洲市场规模和预测（按细胞系类型）
    • 欧洲市场规模和预测（按应用）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区细胞株开发主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（按产品）
    • 按细胞系类型分類的亚太市场规模和预测
    • 亚太地区市场规模与预测（按应用）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲细胞株开发主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按产品）
    • 拉丁美洲市场规模与预测（按细胞系类型）
    • 拉丁美洲市场规模与预测（按应用）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲细胞株开发主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按产品）
    • 中东和非洲市场规模和预测（按细胞系类型）
    • 中东和非洲市场规模及预测（按应用）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 11 章：主要供应商分析 -细胞株开发产业

  • 竞争仪表板
  • 公司简介
    • Lonza
    • Thermo Fisher Scientific
    • WuXi Biologics
    • Catalent
    • Selexis
    • Horizon Discovery
    • Sartorius
    • MilliporeSigma
    • Abcam
    • ATCC
    • Crown Bioscience
    • LakePharma
    • ProBioGen
    • Solentim
    • Horizon Therapeutics

第 12 章：360 度分析师视角

第 13 章：附录

  • 研究方法论
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
Product Code: ANV1807

REPORT HIGHLIGHT

Cell Line Development Market size was valued at USD 4,810 Million in 2022, expanding at a CAGR of 9.81 % from 2023 to 2030.

Cell line development represents a pivotal procedure in the biotechnology and pharmaceutical sectors, involving the creation and curation of specialized cells capable of sustained replication and the expression of desired proteins or traits. Typically, these cells are sourced from either animal or human tissues. These well-established cell lines serve as indispensable tools for research, drug discovery, and the large-scale production of biomanufactured products. The process encompasses cell isolation, modification, and thorough characterization to ensure stability and productivity. Cell lines play an integral role in the manufacturing of biopharmaceuticals, vaccines, and disease-related research, significantly expediting scientific advancements and enabling the efficient development of novel medicines and bioproducts catering to diverse medical and industrial applications.

Cell Line Development Market- Market Dynamics

Growing demand for biopharmaceuticals and personalized medicine propel market demand

The expanding biopharmaceutical industry creates a rising demand for reliable and productive cell lines suitable for the production of complex biotherapeutics, including monoclonal antibodies and gene therapies. Additionally, the emphasis on personalized medicine underscores the necessity for patient-specific cell lines to craft tailored medications and facilitate preclinical testing. This requirement fuels ongoing research and development endeavors aimed at establishing more resilient, high-yield, and versatile cell lines. This, in turn, expedites the advancement and accessibility of novel, targeted therapeutics for a wide spectrum of diseases and medical conditions.

Cell Line Development Market- Key Insights

According to our research analyst's findings, the global Cell Line Development market anticipates an annual growth rate of approximately 4.2% during the forecast period spanning from 2023 to 2030.

The Cell Line Development sector is poised for substantial expansion, primarily attributed to the growing focus on precision medicine within the field of veterinary oncology.

When considering the segmentation by Product, Reagent and Media emerged as the dominant category in the year 2022.

In terms of Type of Cell Lines, Recombinant cell lines took the lead in the Product category in 2022.

Geographically, Asia Pacific led the way in revenue generation in the year 2022.

Cell Line Development Market- Segmentation Analysis:

The global Cell Line Development Market is structured around several key dimensions, including Product, Type of Cell Lines, Application, and Region.

In terms of Product categorization, the market is delineated into four main segments: Reagent and Media, Equipment, Accessories and Consumables, and Services. Notably, Reagent and Media take precedence in this classification. The development of cell lines relies heavily on a variety of specialized reagents and cell culture media. The demand for these essential components is propelled by the necessity to provide an ideal environment for cell growth, maintenance, and productivity. These products are indispensable tools in the establishment and sustenance of high-quality cell lines for applications in both research and biomanufacturing.

Cell Line Development Market- Geographical Insights

From a geographical standpoint, this market encompasses a wide array of regions, including North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. Within these regions, individual countries play a significant role in fostering business activities. The demand for cell line development services and expertise has been steadily on the rise in the Asia-Pacific region. This trend can be attributed to a multitude of factors. Firstly, the burgeoning biotechnology and pharmaceutical sectors in the region have amplified the necessity for reliable cell lines to facilitate drug research and development efforts.

Cell Line Development Market- Competitive Landscape:

The competitive landscape in cell line development is a blend of well-established and emerging enterprises. Companies like Lonza, Thermo Fisher Scientific, and WuXi Biologics offer a comprehensive suite of services and technologies. They engage in competition by showcasing technical innovation, scale, and expertise. On the other hand, smaller firms like Selexis and Solentim focus on specific niches, delivering specialized solutions and cutting-edge platforms.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CELL LINE DEVELOPMENT MARKET KEY PLAYERS

  • Lonza
  • Thermo Fisher Scientific
  • WuXi Biologics
  • Catalent
  • Selexis
  • Horizon Discovery
  • Sartorius
  • MilliporeSigma
  • Abcam
  • ATCC
  • Crown Bioscience
  • LakePharma
  • ProBioGen
  • Solentim
  • Horizon Therapeutics

GLOBAL CELL LINE DEVELOPMENT MARKET, BY PRODUCT

  • Reagent and Media
  • Equipment
  • Accessories and consumables
  • Services

GLOBAL CELL LINE DEVELOPMENT MARKET, BY TYPE OF CELL LINES

  • Recombinant cell lines
  • Hybridomas
  • Continuous cell lines
  • Primary cell lines

GLOBAL CELL LINE DEVELOPMENT MARKET, BY APPLICATION

  • Bioproduction
  • Drug discovery
  • Toxicity testing
  • Tissue engineering
  • Others

GLOBAL CELL LINE DEVELOPMENT MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Cell Line Development Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Cell Line Development Market Snippet by Product
    • 2.1.2. Cell Line Development Market Snippet by Type of Cell Lines
    • 2.1.3. Cell Line Development Market Snippet by Application
    • 2.1.4. Cell Line Development Market Snippet by Country
    • 2.1.5. Cell Line Development Market Snippet by Region
  • 2.2. Competitive Insights

3. Cell Line Development Key Market Trends

  • 3.1. Cell Line Development Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Cell Line Development Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Cell Line Development Market Opportunities
  • 3.4. Cell Line Development Market Future Trends

4. Cell Line Development Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Cell Line Development Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Cell Line Development Market Landscape

  • 6.1. Cell Line Development Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Cell Line Development Market - By Product

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product, 2022 & 2030 (%)
    • 7.1.2. Reagent and Media
    • 7.1.3. Equipment
    • 7.1.4. Accessories and consumables
    • 7.1.5. Services

8. Cell Line Development Market - By Type of Cell Lines

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Type of Cell Lines, 2022 & 2030 (%)
    • 8.1.2. Recombinant cell lines
    • 8.1.3. Hybridomas
    • 8.1.4. Continuous cell lines
    • 8.1.5. Primary cell lines

9. Cell Line Development Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
    • 9.1.2. Bioproduction
    • 9.1.3. Drug discovery
    • 9.1.4. Toxicity testing
    • 9.1.5. Tissue engineering
    • 9.1.6. Others

10. Cell Line Development Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Cell Line Development Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Cell Line Development Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Cell Line Development Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Cell Line Development Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Cell Line Development Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Cell Line Development Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Lonza
    • 11.2.2. Thermo Fisher Scientific
    • 11.2.3. WuXi Biologics
    • 11.2.4. Catalent
    • 11.2.5. Selexis
    • 11.2.6. Horizon Discovery
    • 11.2.7. Sartorius
    • 11.2.8. MilliporeSigma
    • 11.2.9. Abcam
    • 11.2.10. ATCC
    • 11.2.11. Crown Bioscience
    • 11.2.12. LakePharma
    • 11.2.13. ProBioGen
    • 11.2.14. Solentim
    • 11.2.15. Horizon Therapeutics

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data Type of Cell Liness
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Cell Line Development Market: Product Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Product
  • TABLE Global Cell Line Development Market, by Product 2018-2030 (USD Million)
  • TABLE Cell Line Development Market: Type of Cell Lines Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Type of Cell Lines
  • TABLE Global Cell Line Development Market, by Type of Cell Lines 2018-2030 (USD Million)
  • TABLE Cell Line Development Market: Application Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Cell Line Development Market, by Application 2018-2030 (USD Million)
  • TABLE Cell Line Development Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Cell Line Development Market, by Region 2018-2030 (USD Million)
  • TABLE North America Cell Line Development Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Cell Line Development Market, by Product, 2018-2030 (USD Million)
  • TABLE North America Cell Line Development Market, by Type of Cell Lines, 2018-2030 (USD Million)
  • TABLE North America Cell Line Development Market, by Application, 2018-2030 (USD Million)
  • TABLE Europe Cell Line Development Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Cell Line Development Market, by Product, 2018-2030 (USD Million)
  • TABLE Europe Cell Line Development Market, by Type of Cell Lines, 2018-2030 (USD Million)
  • TABLE Europe Cell Line Development Market, by Application, 2018-2030 (USD Million)
  • TABLE Asia Pacific Cell Line Development Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Cell Line Development Market, by Product, 2018-2030 (USD Million)
  • TABLE Asia Pacific Cell Line Development Market, by Type of Cell Lines, 2018-2030 (USD Million)
  • TABLE Asia Pacific Cell Line Development Market, by Application, 2018-2030 (USD Million)
  • TABLE Latin America Cell Line Development Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Cell Line Development Market, by Product, 2018-2030 (USD Million)
  • TABLE Latin America Cell Line Development Market, by Type of Cell Lines, 2018-2030 (USD Million)
  • TABLE Latin America Cell Line Development Market, by Application, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Cell Line Development Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Cell Line Development Market, by Product, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Cell Line Development Market, by Type of Cell Lines, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Cell Line Development Market, by Application, 2018-2030 (USD Million)